Fluorouracil 500mg/10ml Inj 10ml

Manufacturer FRESENIUS KABI Active Ingredient Fluorouracil (Systemic)(flure oh YOOR a sil) Pronunciation FLOOR-oh-YOOR-uh-sill
It is used to treat cancer.
🏷️
Drug Class
Antineoplastic Agent
🧬
Pharmacologic Class
Antimetabolite, Pyrimidine Analog
🤰
Pregnancy Category
Category D
FDA Approved
Jan 1962
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fluorouracil is a chemotherapy drug used to treat various cancers. It works by stopping the growth of cancer cells. It is usually given by injection into a vein.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided to you. It is essential to follow the instructions carefully. This medication is administered as an intravenous injection, either as a single dose or as a continuous infusion over a specified period.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

Missing a Dose

If you miss a dose, contact your doctor to receive guidance on what to do next.
💡

Lifestyle & Tips

  • Avoid contact with people who are sick or have infections, as this medication can weaken your immune system.
  • Report any signs of infection (fever, chills, sore throat) immediately.
  • Practice good oral hygiene to help prevent mouth sores (mucositis). Use a soft toothbrush and rinse your mouth frequently with a mild solution (e.g., baking soda and salt water).
  • Stay well-hydrated and eat a balanced diet, as tolerated.
  • Avoid excessive sun exposure and use sunscreen, as this medication can increase sun sensitivity.
  • Avoid alcohol and tobacco.
  • Use effective birth control during treatment and for a period after, as this drug can harm a developing baby. Discuss with your doctor if you are pregnant or planning to become pregnant.
  • Do not breastfeed during treatment and for a period after.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Highly variable based on indication and regimen. Common regimens include: 12 mg/kg IV once daily for 4 days, then 6 mg/kg IV every other day for 4 doses (max 800 mg/day); or 500 mg/m² IV weekly; or continuous infusion regimens (e.g., 200-300 mg/m²/day continuous IV infusion). Dosing is often part of multi-drug chemotherapy regimens.

Condition-Specific Dosing:

Colorectal Cancer (adjuvant): Often 400 mg/m² IV bolus on Day 1, then 2400 mg/m² continuous IV infusion over 46 hours, every 2 weeks (e.g., FOLFOX, FOLFIRI regimens).
Breast Cancer: Often 500 mg/m² IV on Day 1 and 8 of a 21-day cycle (e.g., CMF regimen).
Gastric Cancer: Often 1000 mg/m² IV continuous infusion over 24 hours on Days 1-5, every 3-4 weeks.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Dosing is highly individualized and based on BSA, similar to adult regimens but less common. Used in specific pediatric oncology protocols.
Adolescent: Dosing is highly individualized and based on BSA, similar to adult regimens but less common. Used in specific pediatric oncology protocols.
⚕️

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required.
Moderate: No specific dose adjustment generally required, but monitor for increased toxicity.
Severe: No specific dose adjustment generally required, but monitor for increased toxicity. Use with caution.
Dialysis: Not significantly removed by dialysis. Administer after dialysis. Monitor for increased toxicity.

Hepatic Impairment:

Mild: No specific dose adjustment generally required.
Moderate: Use with caution. Consider dose reduction (e.g., 30-50%) in patients with significant hepatic dysfunction (e.g., bilirubin > 5 mg/dL or AST > 4x ULN). Monitor for increased toxicity.
Severe: Use with caution. Consider significant dose reduction (e.g., 50% or more) or contraindication. Monitor for increased toxicity.

Pharmacology

🔬

Mechanism of Action

Fluorouracil (5-FU) is a pyrimidine analog antimetabolite. It acts by interfering with DNA and RNA synthesis. 5-FU is metabolized intracellularly to several active metabolites: fluorodeoxyuridine monophosphate (FdUMP), fluorouridine triphosphate (FUTP), and fluorodeoxyuridine triphosphate (FdUTP). FdUMP inhibits thymidylate synthase (TS), an enzyme critical for DNA synthesis, leading to 'thymineless death' of cells. FUTP is incorporated into RNA, disrupting RNA function and protein synthesis. FdUTP is incorporated into DNA, leading to DNA damage and fragmentation. These actions primarily affect rapidly dividing cells, including cancer cells.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable and incomplete orally (0-80%), typically administered intravenously.
Tmax: Not applicable for IV administration (peak concentration achieved rapidly).
FoodEffect: Not applicable for IV administration.

Distribution:

Vd: Approximately 0.12 L/kg (distributes into total body water, CSF, and tumor tissue).
ProteinBinding: Less than 10% (primarily to albumin).
CnssPenetration: Limited (crosses blood-brain barrier, but CSF concentrations are low, typically 10-20% of plasma concentrations).

Elimination:

HalfLife: Biphasic: initial phase 8-20 minutes, terminal phase 20 minutes (dose-dependent).
Clearance: Highly variable, approximately 1.5 L/min/m².
ExcretionRoute: Primarily hepatic metabolism (80-90%), with renal excretion of unchanged drug (5-20%) and metabolites.
Unchanged: 5-20%
⏱️

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of IV administration).
PeakEffect: Not directly applicable for antineoplastic effect, which is cumulative.
DurationOfAction: Cellular effects persist for hours to days due to intracellular metabolism and incorporation into nucleic acids, despite short plasma half-life.

Safety & Warnings

⚠️

BLACK BOX WARNING

Fluorouracil is associated with significant toxicity, including myelosuppression, diarrhea, stomatitis, and nausea/vomiting. Severe and sometimes fatal toxicities are more likely in patients with dihydropyrimidine dehydrogenase (DPD) deficiency. Patients should be carefully monitored for signs of toxicity. Discontinue therapy if severe toxicity occurs. Cardiotoxicity, including angina, ECG changes, and myocardial infarction, has been reported.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of nervous system problems, including:
+ Changes in mood or behavior
+ Confusion
+ Fever
+ Numbness or tingling in the hands or feet
+ Stiff neck
+ Sensitivity to bright lights
+ Severe muscle weakness
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Feeling extremely tired or weak
Chest pain or pressure
Shortness of breath, significant weight gain, or swelling in the arms or legs
Abnormal heartbeat
Dizziness or fainting
Changes in vision
Redness or irritation on the palms of the hands or soles of the feet
Balance problems
Excessive sleepiness
Uncontrolled eye movements
Headache

Administration-Related Side Effects

This medication may cause irritation at the injection site. If the medication leaks from the vein, it can also cause irritation around the affected area. Inform your nurse if you experience any redness, burning, pain, swelling, or fluid leakage at the injection site.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you're concerned about any of the following side effects or if they persist, contact your doctor:

Diarrhea
Upset stomach or vomiting
Decreased appetite
Mouth irritation or mouth sores
Hair loss
Dry skin
Changes in nail condition

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever (100.4°F or higher) or chills
  • Severe diarrhea (more than 4-6 loose stools in 24 hours)
  • Severe mouth sores or difficulty eating/swallowing
  • Unusual bleeding or bruising
  • Severe nausea or vomiting that prevents eating/drinking
  • Redness, swelling, pain, or blistering on hands or feet
  • Chest pain, shortness of breath, or palpitations
  • Signs of infection (e.g., cough, burning urination)
  • Severe fatigue or weakness
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms.
Certain health conditions, such as:
+ Poor nutrition
+ Infections
+ Bone marrow problems, including low white blood cell count, low platelet count, or low red blood cell count
+ Dihydropyrimidine dehydrogenase (DPD) deficiency
* If you are breast-feeding, as you should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests, as directed by your doctor, are crucial to monitor your condition.

This medication can cause low blood cell counts, which may lead to bleeding problems, infections, or anemia. In severe cases, these conditions can be life-threatening. If you have any questions or concerns, discuss them with your doctor. You may be more susceptible to infections, so it is vital to practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

Bleeding can occur more easily while taking this medication. To minimize the risk of injury, be cautious and use a soft toothbrush and an electric razor. If you experience stomach upset, vomiting, diarrhea, or loss of appetite, consult your doctor, as there may be ways to reduce these side effects. If you have diarrhea or vomiting, it is crucial to prevent dehydration and electrolyte imbalances; therefore, discuss the best course of action with your doctor.

Patients who lack the enzyme dihydropyrimidine dehydrogenase (DPD) are at a higher risk of severe and potentially life-threatening side effects, including mouth irritation or sores, diarrhea, low white blood cell counts, and nerve problems.

This medication may increase the risk of heart problems, such as heart attack, heart failure, and abnormal heartbeat, particularly in individuals with a history of heart disease. Discuss your cardiovascular health with your doctor. Before receiving any vaccines, consult your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication.

You may be more prone to sunburn while taking this medication. Take necessary precautions when exposed to the sun, and inform your doctor if you experience increased sensitivity to sunlight. This medication may also affect fertility, leading to difficulties in becoming pregnant or fathering a child. If you plan to conceive, discuss the potential risks with your doctor before starting treatment.

Additionally, this medication may harm an unborn baby if taken during pregnancy. If you or your partner may become pregnant, it is essential to use birth control while taking this medication and for a specified period after the last dose. Your doctor will advise you on the duration of birth control use. If you or your partner becomes pregnant, notify your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Severe myelosuppression (very low white blood cell count, platelets)
  • Severe mucositis (mouth sores)
  • Severe diarrhea
  • Gastrointestinal bleeding
  • Neurotoxicity (ataxia, confusion, seizures, coma)

What to Do:

Seek immediate medical attention. There is no specific antidote for fluorouracil overdose. Management is supportive, including aggressive hydration, antiemetics, antidiarrheals, antibiotics for neutropenic fever, and potentially uridine triacetate (Vistogard) if administered within 96 hours of overdose or early onset of severe toxicity.

Drug Interactions

🚫

Contraindicated Interactions

  • Brivudine (and other antiviral nucleoside analogs like sorivudine): Potentiates fluorouracil toxicity due to inhibition of DPD, leading to fatal outcomes. Co-administration is contraindicated. A washout period of at least 4 weeks is recommended between brivudine and fluorouracil.
🔴

Major Interactions

  • Leucovorin: Enhances the cytotoxic effects of fluorouracil by stabilizing the binding of FdUMP to thymidylate synthase, leading to increased efficacy but also increased toxicity (e.g., myelosuppression, mucositis, diarrhea).
  • Warfarin: Increased INR and bleeding risk due to inhibition of warfarin metabolism or displacement from protein binding.
  • Cimetidine: May increase fluorouracil plasma concentrations by inhibiting its metabolism.
  • Metronidazole: May increase fluorouracil plasma concentrations and toxicity.
  • Thiazide diuretics: May increase myelosuppression.
  • Live vaccines: Risk of severe infection due to immunosuppression.
🟡

Moderate Interactions

  • Phenytoin: May alter phenytoin levels (increase or decrease).
  • Allopurinol: May reduce fluorouracil efficacy by interfering with its activation, but also may reduce toxicity. Clinical significance varies.
  • Tamoxifen: May increase risk of thromboembolic events.
  • Interferon alfa: May increase fluorouracil toxicity.
🟢

Minor Interactions

  • Not available

Monitoring

🔬

Baseline Monitoring

Complete Blood Count (CBC) with differential and platelets

Rationale: To assess baseline hematopoietic function before initiating myelosuppressive therapy.

Timing: Prior to first dose

Liver Function Tests (LFTs) - AST, ALT, bilirubin, alkaline phosphatase

Rationale: To assess baseline hepatic function, as fluorouracil is primarily metabolized by the liver.

Timing: Prior to first dose

Renal Function Tests (RFTs) - BUN, creatinine

Rationale: To assess baseline renal function, as a portion of the drug is renally excreted.

Timing: Prior to first dose

DPD deficiency testing (optional, but highly recommended)

Rationale: To identify patients at high risk for severe, life-threatening toxicity due to impaired fluorouracil metabolism.

Timing: Prior to first dose

Cardiac evaluation (ECG, echocardiogram)

Rationale: To assess baseline cardiac function, especially in patients with pre-existing cardiac disease, due to risk of cardiotoxicity.

Timing: Prior to first dose, if indicated

📊

Routine Monitoring

Complete Blood Count (CBC) with differential and platelets

Frequency: Prior to each dose/cycle and weekly during continuous infusion regimens

Target: WBC > 3,500/mm³, ANC > 1,500/mm³, Platelets > 100,000/mm³ (may vary by protocol)

Action Threshold: Hold or reduce dose if ANC < 1,500/mm³ or platelets < 100,000/mm³ (specific thresholds vary by protocol and severity of myelosuppression)

Assessment for GI toxicity (diarrhea, mucositis, nausea/vomiting)

Frequency: Daily during treatment and for several weeks post-treatment

Target: Not applicable

Action Threshold: Hold or reduce dose for Grade 2 or higher diarrhea/mucositis; manage symptoms aggressively.

Assessment for Hand-Foot Syndrome (palmar-plantar erythrodysesthesia)

Frequency: Weekly during treatment and for several weeks post-treatment

Target: Not applicable

Action Threshold: Hold or reduce dose for Grade 2 or higher symptoms; manage symptoms.

Liver Function Tests (LFTs)

Frequency: Periodically, as per protocol (e.g., every 1-2 cycles)

Target: Within normal limits or stable

Action Threshold: Investigate significant elevations; consider dose adjustment if severe.

Renal Function Tests (RFTs)

Frequency: Periodically, as per protocol (e.g., every 1-2 cycles)

Target: Within normal limits or stable

Action Threshold: Investigate significant elevations; consider dose adjustment if severe.

👁️

Symptom Monitoring

  • Fever (sign of infection/neutropenic fever)
  • Sore mouth/throat, difficulty swallowing (mucositis)
  • Diarrhea (frequency, consistency, presence of blood)
  • Nausea, vomiting
  • Redness, swelling, pain, blistering on palms of hands and soles of feet (Hand-Foot Syndrome)
  • Chest pain, shortness of breath, palpitations (cardiotoxicity)
  • Unusual bleeding or bruising
  • Fatigue, weakness
  • Signs of neurotoxicity (ataxia, confusion, lethargy, headache)

Special Patient Groups

🤰

Pregnancy

Fluorouracil is classified as Pregnancy Category D. It can cause fetal harm when administered to a pregnant woman. It is teratogenic and embryotoxic in animals. Avoid use during pregnancy.

Trimester-Specific Risks:

First Trimester: High risk of major congenital malformations and fetal death.
Second Trimester: Risk of fetal growth restriction, organ toxicity, and developmental abnormalities.
Third Trimester: Risk of fetal growth restriction, myelosuppression, and other toxicities.
🤱

Lactation

It is not known whether fluorouracil is excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, breastfeeding is contraindicated during fluorouracil therapy and for a period after the last dose (e.g., 1 week).

Infant Risk: High risk of serious adverse effects, including myelosuppression, immunosuppression, and potential carcinogenicity.
👶

Pediatric Use

Safety and effectiveness in pediatric patients have not been established in controlled clinical trials for most indications. Use is limited to specific pediatric oncology protocols where the benefits outweigh the risks. Dosing is typically based on body surface area (BSA). Pediatric patients may be more susceptible to certain toxicities.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may have reduced renal or hepatic function, or more comorbidities, requiring careful monitoring and potential dose adjustments. Increased risk of myelosuppression and diarrhea may be observed.

Clinical Information

💎

Clinical Pearls

  • DPD deficiency is a critical pharmacogenomic consideration. Pre-screening for DPD deficiency is highly recommended, especially for patients receiving bolus or high-dose continuous infusion regimens, as it can lead to severe, life-threatening, or fatal toxicity.
  • Leucovorin is often co-administered with fluorouracil to enhance its cytotoxic effect, but this also increases toxicity. The sequence and timing of administration are crucial.
  • Monitor closely for myelosuppression (neutropenia, thrombocytopenia) and gastrointestinal toxicities (mucositis, diarrhea), which are dose-limiting. Aggressive supportive care is essential.
  • Hand-Foot Syndrome (palmar-plantar erythrodysesthesia) is a common and often dose-limiting toxicity, particularly with continuous infusions. Patient education on prevention and management is important.
  • Cardiotoxicity, though less common, can be severe and includes angina, myocardial infarction, and arrhythmias. Patients with pre-existing cardiac disease should be monitored carefully.
  • Uridine triacetate (Vistogard) is an antidote for fluorouracil overdose or severe, early-onset toxicity, but must be administered within 96 hours of fluorouracil administration.
🔄

Alternative Therapies

  • Other antimetabolites (e.g., Methotrexate, Gemcitabine, Pemetrexed, Cytarabine)
  • Other classes of chemotherapy agents depending on cancer type (e.g., platinum agents, taxanes, topoisomerase inhibitors)
  • Targeted therapies (e.g., EGFR inhibitors, VEGF inhibitors)
  • Immunotherapy (e.g., PD-1/PD-L1 inhibitors)
💰

Cost & Coverage

Average Cost: Varies widely, typically $50 - $200 per 500mg/10ml vial per 500mg/10ml vial
Generic Available: Yes
Insurance Coverage: Tier 4 (Specialty/Chemotherapy drug), typically covered under medical benefit for oncology indications.
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance.

To ensure safe use, do not share your medication with others, and never take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion.

Proper disposal of unused or expired medications is crucial. Do not dispose of them by flushing down the toilet or pouring down the drain unless specifically instructed to do so. If you are unsure about the correct disposal method, consult your pharmacist for guidance. Many communities have drug take-back programs, which your pharmacist can help you locate.

Some medications may come with an additional patient information leaflet. Check with your pharmacist to see if this applies to your prescription. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred, as this will aid in prompt and effective treatment.